M. Verlinden

2.7k total citations
50 papers, 2.2k citations indexed

About

M. Verlinden is a scholar working on Gastroenterology, Surgery and Nutrition and Dietetics. According to data from OpenAlex, M. Verlinden has authored 50 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Gastroenterology, 20 papers in Surgery and 7 papers in Nutrition and Dietetics. Recurrent topics in M. Verlinden's work include Gastroesophageal reflux and treatments (15 papers), Gastrointestinal motility and disorders (15 papers) and Helicobacter pylori-related gastroenterology studies (12 papers). M. Verlinden is often cited by papers focused on Gastroesophageal reflux and treatments (15 papers), Gastrointestinal motility and disorders (15 papers) and Helicobacter pylori-related gastroenterology studies (12 papers). M. Verlinden collaborates with scholars based in Belgium, United States and Australia. M. Verlinden's co-authors include Michael Jones, Nicholas J. Talley, N. J. Talley, Wei Sun, N W Read, H. Deelstra, G. N. J. Tytgat, J.-C. van der Auwera, M. van Sprundel and Yvan Vandenplas and has published in prestigious journals such as The Lancet, Gastroenterology and Biological Psychiatry.

In The Last Decade

M. Verlinden

50 papers receiving 2.0k citations

Peers

M. Verlinden

GASTR

SURGE

PHYSI

HTM

Erik Muls Belgium

William D. Heizer United States

Kjell Hellström Sweden

W.S. Nimmo United Kingdom

George E. Dukes United States

P. E. Harding Australia

Shoaib Faruqi United Kingdom

Gianfranco Salvioli Italy

Patricia W. Mueller United States

R. G. McAllister United States

Erik Muls Belgium

M. Verlinden

377 ×0.3

GASTR

737 ×0.8

SURGE

799 ×2.2

PHYSI

244 ×0.8

29 ×0.2

HTM

Citations per year, relative to M. Verlinden M. Verlinden (= 1×) peers Erik Muls

Countries citing papers authored by M. Verlinden

Since Specialization

Citations

This map shows the geographic impact of M. Verlinden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Verlinden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Verlinden more than expected).

Fields of papers citing papers by M. Verlinden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Verlinden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Verlinden. The network helps show where M. Verlinden may publish in the future.

Co-authorship network of co-authors of M. Verlinden

This figure shows the co-authorship network connecting the top 25 collaborators of M. Verlinden. A scholar is included among the top collaborators of M. Verlinden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Verlinden. M. Verlinden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilens, Timothy E., M. Verlinden, Lenard A. Adler, Patricia J. Wozniak, & Scott A. West. (2006). ABT-089, A Neuronal Nicotinic Receptor Partial Agonist, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Pilot Study. Biological Psychiatry. 59(11). 1065–1070. 94 indexed citations

Orr, William C., M. Verlinden, Dennis Riff, et al.. (2002). Efficacy of a motilin receptor agonist (ABT‐229) for the treatment of gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. 16(4). 749–757. 13 indexed citations

Dutta, Sandeep, et al.. (2002). Single‐ and Multiple‐Dose Pharmacokinetics of Fiduxosin under Nonfasting Conditions in Healthy Male Subjects. The Journal of Clinical Pharmacology. 42(5). 540–546. 1 indexed citations

Jones, Michael, et al.. (2001). Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. The American Journal of Gastroenterology. 96(3). 689–696. 133 indexed citations

Talley, N. J., M. Verlinden, & Michael Jones. (2001). Can Symptoms Discriminate Among Those With Delayed or Normal Gastric Emptying in Dysmotility-Like Dyspepsia?. The American Journal of Gastroenterology. 96(5). 1422–1428. 151 indexed citations

Talley, Nicholas J., M. Verlinden, & Michael Jones. (2001). Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10‐item short form. Alimentary Pharmacology & Therapeutics. 15(2). 207–216. 112 indexed citations

Camilleri, Michael, et al.. (2000). Toward Office-Based Measurement of Gastric Emptying in Symptomatic Diabetics Using [13C]Octanoic Acid Breath Test. The American Journal of Gastroenterology. 95(10). 2751–2761. 70 indexed citations

Talley, Nicholas J., M. Verlinden, William J. Snape, et al.. (2000). Failure of a motilin receptor agonist (ABT‐229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double‐blind placebo‐controlled trial. Alimentary Pharmacology & Therapeutics. 14(12). 1653–1661. 182 indexed citations

Depoortere, Inge, M. Verlinden, Theo Thijs, & Gert Van Assche. (1999). The motilide ABT-299 selectively downregulates motilin receptors in different tissues. Evidence for motilin receptor subtyes. Gastroenterology. 116(4). 2 indexed citations

10.

Wright, Teresa L., et al.. (1999). ERYTHROMYCIN DERIVATIVES ABT 229 AND GM 611 ACT ON MOTILIN RECEPTORS IN THE RABBIT DUODENUM. Clinical and Experimental Pharmacology and Physiology. 26(3). 242–245. 28 indexed citations

11.

Furness, John B., et al.. (1999). AN ACTION OF ERYTHROMYCIN IN THE INTESTINE THAT IS NOT MEDIATED VIA MOTILIN RECEPTORS. Clinical and Experimental Pharmacology and Physiology. 26(2). 100–104. 16 indexed citations

12.

Tytgat, G. N. J., et al.. (1995). Prognostic factors for relapse and maintenance treatment with cisapride in gastro—oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. 9(3). 271–280. 19 indexed citations

13.

Blum, A. L., et al.. (1993). Effect of cisapride on relapse of esophagitis. Digestive Diseases and Sciences. 38(3). 551–560. 65 indexed citations

14.

Awouters, F., Anton A. H. P. Megens, M. Verlinden, et al.. (1993). Loperamide. Digestive Diseases and Sciences. 38(6). 977–995. 90 indexed citations

15.

Veereman-Wauters, G, Johan Monbaliu, W. Meuldermans, et al.. (1991). Study of the placental transfer of cisapride in sheep. Plasma levels in the pregnant ewe, the fetus, and the lamb.. Drug Metabolism and Disposition. 19(1). 168–172. 9 indexed citations

16.

Vandenplas, Yvan, et al.. (1989). Gastroesophageal Reflux Incidence and Respiratory Dysfunction During Sleep in Infants. Journal of Pediatric Gastroenterology and Nutrition. 8(1). 31–36. 39 indexed citations

17.

Verlinden, M.. (1989). Review article: a role for gastrointestinal prokinetic agents in the treatment of reflux oesophagitis?. Alimentary Pharmacology & Therapeutics. 3(2). 113–131. 27 indexed citations

18.

Marbaix, Étienne, et al.. (1988). Treatment with Cisapride of the gastrointestinal and urological sequelae of spinal cord transection: case report. Spinal Cord. 26(3). 162–164. 20 indexed citations

19.

Verlinden, M., et al.. (1983). The selenium status of Belgian population groups. Biological Trace Element Research. 5(2). 91–102. 37 indexed citations

20.

Verlinden, M.. (1981). The determination of selenium by atomic-absorption spectrometry: A review. Talanta. 28(9). 637–646. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact